|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.600 USD | +1.23% |
|
+10.18% | -38.26% |
| 08-28 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 330M 285M 269M 244M 458M 31.56B 461M 3.2B 1.23B 16.05B 1.24B 1.21B 50.73B | P/E 2026 * |
-11.8x | P/E 2027 * | -15x |
|---|---|---|---|---|---|
| Enterprise Value | 330M 285M 269M 244M 458M 31.56B 461M 3.2B 1.23B 16.05B 1.24B 1.21B 50.73B | EV / Sales 2026 * |
22.2x | EV / Sales 2027 * | 16.7x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript : CapsoVision, Inc.
| 1 day | +1.23% | ||
| 1 week | +10.18% | ||
| Current month | +13.01% | ||
| 1 month | -2.80% | ||
| 3 months | -8.21% | ||
| 6 months | +19.57% | ||
| Current year | -38.26% |
| 1 week | 5.99 |  | 6.99 |
| 1 month | 5.75 | | 6.99 |
| Current year | 4.5 | | 11.37 |
| 1 year | 4.08 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Director | 61,068 | 0.1225% | ||
| 08/07/26 | Buy | Director | 81,300 | 0.1631% | ||
| 01/07/26 | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.23% | +10.18% | +60.19% | - | 330M | |
| +0.73% | -5.04% | -31.76% | -2.36% | 12.56B | |
| -2.07% | -2.38% | +11.19% | +11.63% | 4.13B | |
| -3.46% | -4.65% | -46.75% | -58.56% | 1.21B | |
| -2.76% | -5.97% | -44.19% | -44.43% | 1.07B | |
| +0.43% | -1.47% | +15.36% | +86.02% | 1.05B | |
| -1.47% | -7.83% | - | - | 954M | |
| -2.35% | -6.69% | -41.36% | - | 953M | |
| -4.21% | -3.00% | +27.85% | +96.59% | 489M | |
| +3.39% | -0.14% | -68.42% | +315.52% | 244M | |
| Average | -1.05% | -3.58% | -13.10% | +57.77% | 2.3B | |
| Weighted average by Cap. | -0.46% | -4.48% | -21.00% | +5.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.81M 12.13M 11M 20.63M 1.42B 20.74M 144M 55.41M 723M 55.86M 54.63M 2.28B | 19.82M 17.08M 16.17M 14.66M 27.5M 1.89B 27.64M 192M 73.86M 963M 74.45M 72.81M 3.04B |
| Net income | -27.56M -23.74M -22.48M -20.38M -38.23M -2.63B -38.42M -267M -103M -1.34B -103M -101M -4.23B | -22.1M -19.04M -18.03M -16.34M -30.66M -2.11B -30.81M -214M -82.34M -1.07B -83M -81.18M -3.39B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | $6.600 | +1.23% | 207,060 |
| 10/09/26 | $6.520 | +2.35% | 163,623 |
| 09/09/26 | $6.370 | +0.16% | 185,251 |
| 08/09/26 | $6.360 | +6.18% | 391,401 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.600USD
Average target price
9.500USD
Spread / Average Target
+43.94%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
